Literature DB >> 12429654

Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in Vivo.

Marcela F Bolontrade1, Rong-Rong Zhou, Eugenie S Kleinerman.   

Abstract

Vasculogenesis, the process by which endothelial cell precursors are recruited and organized to form a vasculature, has traditionally been thought to play a role only in embryonic development. However, several studies have now been published suggesting that vasculogenesis may have a role in the formation of new vascular networks during postnatal life. Recent studies suggest the existence of circulating endothelial precursor cells that arise from outside the place of vascularization. Using a mouse bone marrow (BM) transplantation model that takes advantage of MHC haplotype differences between donor and recipient mice, we examined the contribution of donor BM-derived cells to neovascularization in recipient nude mice with developing Ewing's sarcoma tumors. We found that the donor BM cells gave rise to endothelial cells in vitro and colocalized with neovessels in Ewing's sarcomas in vivo. We also found that donor BM-derived cells were involved in the formation of the tumor vasculature. Our findings indicate that not only angiogenesis but also vasculogenesis was involved in the development of Ewing's sarcoma in our mouse model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429654

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  22 in total

1.  Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung.

Authors:  Zhichao Zhou; Keri Schadler Stewart; Ling Yu; Eugenie S Kleinerman
Journal:  Angiogenesis       Date:  2010-12-24       Impact factor: 9.596

2.  Monocytes form a vascular barrier and participate in vessel repair after brain injury.

Authors:  John Glod; David Kobiler; Martha Noel; Rajeth Koneru; Shoshana Lehrer; Daniel Medina; Dragan Maric; Howard A Fine
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

3.  VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.

Authors:  Krishna Reddy; Ying Cao; Zhichao Zhou; Ling Yu; Shu-Fang Jia; Eugenie S Kleinerman
Journal:  Angiogenesis       Date:  2008-03-16       Impact factor: 9.596

Review 4.  Murine bone marrow-derived mesenchymal stem cells as vehicles for interleukin-12 gene delivery into Ewing sarcoma tumors.

Authors:  Xiaoping Duan; Hui Guan; Ying Cao; Eugenie S Kleinerman
Journal:  Cancer       Date:  2009-01-01       Impact factor: 6.860

5.  Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.

Authors:  Krishna Reddy; Zhichao Zhou; Shu-Fang Jia; Tim H Lee; Jaime Morales-Arias; Ying Cao; Eugenie S Kleinerman
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

Review 6.  Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives.

Authors:  Pete Anderson; Maritza Salazar-Abshire
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

7.  Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.

Authors:  Randala Hamdan; Zhichao Zhou; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

8.  Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels.

Authors:  Krishna Reddy; Zhichao Zhou; Keri Schadler; Shu-Fang Jia; Eugenie S Kleinerman
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

Review 9.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

Review 10.  Ewing's sarcoma: standard and experimental treatment options.

Authors:  Vivek Subbiah; Pete Anderson; Alexander J Lazar; Emily Burdett; Kevin Raymond; Joseph A Ludwig
Journal:  Curr Treat Options Oncol       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.